175 related articles for article (PubMed ID: 9464843)
61. IL-4 and prostaglandin E2 inhibit hypomethylation of the 5' regulatory region of IFN-gamma gene during differentiation of naive CD4+ T cells.
Katamura K; Fukui T; Kiyomasu T; Iio J; Tai G; Ueno H; Heike T; Mayumi M; Furusho K
Mol Immunol; 1998 Jan; 35(1):39-45. PubMed ID: 9683262
[TBL] [Abstract][Full Text] [Related]
62. Endogenous PGE2 promotes the induction of human Th17 responses by fungal ß-glucan.
Gagliardi MC; Teloni R; Mariotti S; Bromuro C; Chiani P; Romagnoli G; Giannoni F; Torosantucci A; Nisini R
J Leukoc Biol; 2010 Nov; 88(5):947-54. PubMed ID: 20807707
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of TNF receptor signaling by anti-TNFα biologicals primes naïve CD4(+) T cells towards IL-10(+) T cells with a regulatory phenotype and function.
Boks MA; Kager-Groenland JR; Mousset CM; van Ham SM; ten Brinke A
Clin Immunol; 2014 Apr; 151(2):136-45. PubMed ID: 24568737
[TBL] [Abstract][Full Text] [Related]
64. Evaluation of the impact of arginine-chitosan/DNA nanoparticles on human naive CD4+ T cells.
Liu L; Bai Y; Zhu D; Song L; Wang H; Dong X; Zhang H; Leng X
J Biomed Mater Res A; 2011 Jan; 96(1):170-6. PubMed ID: 21105165
[TBL] [Abstract][Full Text] [Related]
65. Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.
Loza MJ; Foster S; Peters SP; Penn RB
Blood; 2006 Mar; 107(5):2052-60. PubMed ID: 16278302
[TBL] [Abstract][Full Text] [Related]
66. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
Alleva DG; Burger CJ; Elgert KD
Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
[TBL] [Abstract][Full Text] [Related]
67. The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype.
Dooper MM; Wassink L; M'Rabet L; Graus YM
Immunology; 2002 Sep; 107(1):152-9. PubMed ID: 12225374
[TBL] [Abstract][Full Text] [Related]
68. Neisseria gonorrhoeae triggers the PGE2/IL-23 pathway and promotes IL-17 production by human memory T cells.
Stefanelli P; Teloni R; Carannante A; Mariotti S; Nisini R; Gagliardi MC
Prostaglandins Other Lipid Mediat; 2012 Oct; 99(1-2):24-9. PubMed ID: 22542425
[TBL] [Abstract][Full Text] [Related]
69. Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines.
Nori M; Iwata S; Munakata Y; Kobayashi H; Kobayashi S; Umezawa Y; Hosono O; Kawasaki H; Dang NH; Tanaka H; Shiohara T; Morimoto C
Clin Exp Allergy; 2003 Nov; 33(11):1544-54. PubMed ID: 14616867
[TBL] [Abstract][Full Text] [Related]
70. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: relationship with cell proliferation.
Marie PJ; Hott M; Launay JM; Graulet AM; Gueris J
J Clin Endocrinol Metab; 1993 Sep; 77(3):824-30. PubMed ID: 8370705
[TBL] [Abstract][Full Text] [Related]
71. CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells.
Demeure CE; Byun DG; Yang LP; Vezzio N; Delespesse G
Immunology; 1996 May; 88(1):110-5. PubMed ID: 8707335
[TBL] [Abstract][Full Text] [Related]
72. The cyclopentenone prostaglandin PGA2 costimulates the maturation of human dendritic cells.
Thurnher M; Putz T; Gander H; Rahm A; Bartsch G; Ramoner R
Exp Hematol; 2005 Feb; 33(2):144-50. PubMed ID: 15676206
[TBL] [Abstract][Full Text] [Related]
73. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.
van der Pouw Kraan TC; Boeije LC; Smeenk RJ; Wijdenes J; Aarden LA
J Exp Med; 1995 Feb; 181(2):775-9. PubMed ID: 7836930
[TBL] [Abstract][Full Text] [Related]
74. The role of inflammatory mediators in the pathogenesis of periodontal disease.
Page RC
J Periodontal Res; 1991 May; 26(3 Pt 2):230-42. PubMed ID: 1679130
[TBL] [Abstract][Full Text] [Related]
75. Naive CD4+ T cells can be sensitized with IL-7.
Vakkila J; Aystö S; Saarinen-Pihkala UM; Sariola H
Scand J Immunol; 2001 Nov; 54(5):501-5. PubMed ID: 11696202
[TBL] [Abstract][Full Text] [Related]
76. Regulation by PGE2 of IL-2, IL-3 and IFN production by cortico-resistant thymocytes.
Daculsi R; Vaillier D; Gualde N
Immunol Lett; 1993 Nov; 38(3):229-35. PubMed ID: 7510266
[TBL] [Abstract][Full Text] [Related]
77. Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells.
Okada F; Hosokawa M; Hasegawa J; Kuramitsu Y; Nakai K; Yuan L; Lao H; Kobayashi H; Takeichi N
Br J Cancer; 1994 Aug; 70(2):233-8. PubMed ID: 8054271
[TBL] [Abstract][Full Text] [Related]
78. Differential effects of cyclo-oxygenase pathway metabolites on cytokine production by T lymphocytes.
Della Bella S; Molteni M; Compasso S; Zulian C; Vanoli M; Scorza R
Prostaglandins Leukot Essent Fatty Acids; 1997 Mar; 56(3):177-84. PubMed ID: 9089795
[TBL] [Abstract][Full Text] [Related]
79. Regulation of CD31 expression and interleukin-4 production by human cord blood CD4+ T cells with interleukin-4 and interleukin-7.
Katamura K; Fukui T; Kiyomasu T; Ohmura K; Iio J; Ueno H
Pediatr Int; 2000 Apr; 42(2):126-33. PubMed ID: 10804726
[TBL] [Abstract][Full Text] [Related]
80. Prostaglandin E2 inhibits IL-10 production by bovine CD4+ T cells.
Zuśka-Prot M; Maślanka T; Jasiecka A; Jaroszewski JJ
Pol J Vet Sci; 2014; 17(3):511-3. PubMed ID: 25286662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
